Profiles-biocentury-com.proxy.lib.umich.edu

Profiles-biocentury-com.proxy.lib.umich.edu has Server used 141.211.4.224 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first Unknown and hosted in Ann Arbor United States, server ping response time 50 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Profiles-biocentury-com keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

Notice! No data available for this site.

Hosting Provider

Website: Profiles-biocentury-com.proxy.lib.umich.edu
Hostname: sherry.umdl.umich.edu
Country:
NetName:
Address: see http,
Region: MI
City: Ann Arbor
Postal Code: 48109
Latitude: 42.277599334717
Longitude: -83.740898132324
Area Code: 734
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Revo.com (1 day ago)

   » Bobbyjonesband.com (1 day ago)

   » Huishoubao.com (15 hours ago)

   » M1file.com (3 day ago)

   » Renhomesantalya.com (5 hours ago)

   » Napadrivertours.com (3 hours ago)

   » Barefootconsultants.com (13 hours ago)

Results For Websites Listing

Found 28 Websites with content related to this domain, It is result after search with search engine

Company Profiles

Profiles.biocentury.com   DA: 23 PA: 10 MOZ Rank: 33

  • For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making
  • Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the biopharma industry and

Nexavar, Sorafenib (BAY 43-9006)

Profiles.biocentury.com   DA: 23 PA: 17 MOZ Rank: 41

  • For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making
  • Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the biopharma industry and

Bavencio, Avelumab (MSB0010718C, PF-06834635

Profiles.biocentury.com   DA: 23 PA: 21 MOZ Rank: 46

  • For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making
  • Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the biopharma industry and

Do-Coop Technologies Ltd.

Profiles.biocentury.com   DA: 23 PA: 35 MOZ Rank: 61

  • For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making
  • Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the biopharma industry and

Peloton Therapeutics Inc.

Profiles.biocentury.com   DA: 23 PA: 35 MOZ Rank: 62

  • For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, BCIQ provides accurate information and context to support profitable and strategic decision making
  • Unlike other intelligence solutions, BCIQ exclusively supports the unique needs of the biopharma industry and

Emerging Company Profile Collection

Cms.biocentury.com   DA: 18 PA: 50 MOZ Rank: 73

  • Emerging Company Profile Collection
  • The world of drug development is rapidly changing, driven by the dramatic evolution of technology and science
  • Big data and analytics now play a key role in driving decisions throughout the drug development process – influencing everything from product vision and asset valuation discussions, to

About BioCentury

Biocentury.com   DA: 18 PA: 23 MOZ Rank: 47

  • BioCentury is known for organizing and hosting conferences and other events around the world that help biopharma executives, investors and researchers build and expand their networks
  • Our events bring key opinion leaders in the industry together for strategic discussions, thought-provoking panels, company presentations, 1x1 meetings and

Juli Balestrieri

Zoominfo.com   DA: 16 PA: 30 MOZ Rank: 53

  • View Juli Balestrieri's business profile as Business Development Manager at BioCentury
  • Find contact's direct phone number, email address, work history, and more.

Jeff Cranmer

Zoominfo.com   DA: 16 PA: 26 MOZ Rank: 50

  • View Jeff Cranmer's business profile as Executive Editor at BioCentury
  • Find contact's direct phone number, email address, work history, and more.

Eric Pierce

Linkedin.com   DA: 16 PA: 23 MOZ Rank: 48

  • View Eric Pierce’s profile on LinkedIn, the world’s largest professional community
  • Eric has 3 jobs listed on their profile
  • See the complete profile on LinkedIn and discover Eric’s

Alicia Parker

Zoominfo.com   DA: 16 PA: 28 MOZ Rank: 54

  • View Alicia Parker's business profile as Staff Writer at BioCentury
  • Find contact's direct phone number, email address, work history, and more.

Aaron Gadowski

Linkedin.com   DA: 16 PA: 17 MOZ Rank: 44

  • Director of Product Management at BioCentury Inc
  • St Petersburg, Florida, United States 500+ connections
  • Join to Connect Show more profiles Show fewer profiles

Spark Therapeutics Llc

Easy-online-courses.com   DA: 27 PA: 30 MOZ Rank: 69

  • Spark Therapeutics Enters into Definitive Merger … › On roundup of the best Online Courses on www.sparktx.com Courses
  • Posted: (1 week ago) Spark Therapeutics Enters into Definitive Merger Agreement with Roche
  • Roche to acquire Spark Therapeutics for $114.50 per share representing a total equity value of $4.8 billion Spark Therapeutics will continue its operations in Philadelphia as an

Christy Wong

Linkedin.com   DA: 16 PA: 26 MOZ Rank: 55

  • View Christy Wong’s profile on LinkedIn, the world’s largest professional community
  • Christy has 10 jobs listed on their profile. See the complete profile on LinkedIn and

Recently Analyzed Sites

Revo.com (1 day ago)

Bobbyjonesband.com (1 day ago)

Huishoubao.com (15 hours ago)

M1file.com (3 day ago)

Renhomesantalya.com (5 hours ago)

Napadrivertours.com (3 hours ago)

Trekksoft.com (8 day ago)

Tibbo.com (7 hours ago)

Bbwdatesites.com (1 seconds ago)

Tailspinbandsc.com (4 day ago)

Dungscanada.com (1 day ago)

Jfsorange.org (12 day ago)

Marloweslu.com (3 hours ago)